Last updated at 08 Mar 2024 12:00 PM
Director
DIN: 00344237
Ameeta Janak Patel is currently associated with 2 companies as Director. They serve as a Director at TROIKAA PHARMACEUTICALS LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 00344237.Ameeta Janak Patel has previously been associated with 1 company in roles such as Additional Director.Ameeta Janak Patel is currently involved in 1 different role. Their most recent position is with TROIKAA PHARMACHEM PRIVATE LIMITED as a Director. The first company Ameeta Janak Patel was appointed to as a director was TROIKAA PHARMACEUTICALS LIMITED. Ameeta Janak Patel is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Ameeta Janak Patel is currently associated with 2 companies as Director. They serve as a Director at TROIKAA PHARMACEUTICALS LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 00344237.Ameeta Janak Patel has previously been associated with 1 company in roles such as Additional Director.Ameeta Janak Patel is currently involved in 1 different role. Their most recent position is with TROIKAA PHARMACHEM PRIVATE LIMITED as a Director. The first company Ameeta Janak Patel was appointed to as a director was TROIKAA PHARMACEUTICALS LIMITED. Ameeta Janak Patel is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Female
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (1)
4y 2m 2y 1m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| TROIKAA PHARMACEUTICALS LIMITED | Director | 15-Jun-2005 |
| TROIKAA PHARMACEUTICALS LIMITED | Director | 29-Sep-2016 |
| TROIKAA PHARMACHEM PRIVATE LIMITED | Director | 08-Nov-2021 |